What's in Universidad Central del Caribe's pipeline?

Universidad Central del Caribe has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Universidad Central del Caribe's portfolio?

Top competitors by shared drug class: ABX advanced biochemical compounds GmbH, Central Hospital, Nancy, France, Centre hospitalier de l'Université de Montréal (CHUM), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Institute for Neurodegenerative Disorders.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidad-central-del-caribe.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Universidad Central del Caribe — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidad Central del Caribe pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ABX advanced biochemical compounds GmbH · 1 shared drug class
Central Hospital, Nancy, France · 1 shared drug class
Centre hospitalier de l'Université de Montréal (CHUM) · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
Institute for Neurodegenerative Disorders · 1 shared drug class
OHSU Knight Cancer Institute · 1 shared drug class
Piramal Imaging Limited · 1 shared drug class
SOFIE · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidad Central del Caribe:

Cite this brief

Drug Landscape (2026). Universidad Central del Caribe — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidad-central-del-caribe. Accessed 2026-05-17.